Cerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease

P-15L Bone Graft is currently being studied in the Company's ASPIRE IDE clinical trial WESTMINSTER, Colo., April 29, 2021 -- (Healthcare Sales & Marketing Network) -- Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bon... Devices, Orthopaedic, Neurosurgery, FDA Cerapedics, Bone Graft, degenerative disc disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news